Announcement • Apr 09
Stark Power Ltd announced that it expects to receive ILS 139.999995 million in funding from More Investment House Ltd., Arkin Capital, Noked Capital Ltd. Stark Power Ltd has announced to issue 18,666,666 of ordinary shares at a price of ILS 7.50 per share for gross proceeds of ILS 139.999995 on April 7, 2026. short-term warrants at ILS 7.50 per share (through October 1, 2026) and long-term warrants at ILS 10.00 per share (through October 1, 2029), representing potential additional proceeds of ILS 75,000,000 for total aggregates of ILS 215,000,000.The transaction includes institutional investors, including Alpha Opportunities Fund, Harel Insurance, Phoenix Insurance Company, More Investment House, Noked Capital, and Arkin Capital, alongside other institutions. Completion of the offering is subject to customary closing conditions. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₪11.93, the stock trades at a trailing P/E ratio of 26.9x. Average trailing P/E is 23x in the Electronic industry in Israel. Total returns to shareholders of 949% over the past three years. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₪10.00, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 23x in the Electronic industry in Israel. Total returns to shareholders of 870% over the past three years. New Risk • Mar 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (68% average weekly change). Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Large one-off items impacting financial results. Market cap is less than US$100m (₪45.2m market cap, or US$14.4m). Valuation Update With 7 Day Price Move • Feb 18
Investor sentiment improves as stock rises 37% After last week's 37% share price gain to ₪8.25, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 21x in the Electronic industry in Israel. Total returns to shareholders of 547% over the past three years. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₪7.74, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 22x in the Electronic industry in Israel. Total returns to shareholders of 467% over the past three years. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₪2.48, the stock trades at a trailing P/E ratio of 5.6x. Average trailing P/E is 20x in the Electronic industry in Israel. Total returns to shareholders of 105% over the past three years. Valuation Update With 7 Day Price Move • Dec 05
Investor sentiment deteriorates as stock falls 31% After last week's 31% share price decline to ₪3.07, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 17x in the Electronic industry in Israel. Total returns to shareholders of 140% over the past three years. Valuation Update With 7 Day Price Move • Nov 19
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₪2.71, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 17x in the Electronic industry in Israel. Total returns to shareholders of 79% over the past three years. Announcement • Sep 17
E.E.A.M.I Ltd, Annual General Meeting, Oct 22, 2025 E.E.A.M.I Ltd, Annual General Meeting, Oct 22, 2025. Location: teshuva law offices, Israel Board Change • May 06
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Amir Fishelov was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Mar 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 11% per year over the past 5 years. Market cap is less than US$10m (₪7.45m market cap, or US$2.04m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Revenue is less than US$5m (US$3.0m revenue). Board Change • Nov 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Amir Fishelov was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Nov 11
Ecoppia Scientific Ltd, Annual General Meeting, Dec 15, 2024 Ecoppia Scientific Ltd, Annual General Meeting, Dec 15, 2024. Location: v.teshuva law offices, Israel Reported Earnings • Apr 03
Full year 2023 earnings released: US$0.14 loss per share (vs US$0.22 loss in FY 2022) Full year 2023 results: US$0.14 loss per share (improved from US$0.22 loss in FY 2022). Net loss: US$13.6m (loss narrowed 37% from FY 2022). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings. New Risk • Mar 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.7% average weekly change). Earnings have declined by 23% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (US$3.6m revenue). Market cap is less than US$100m (₪128.5m market cap, or US$35.2m). Announcement • Dec 14
Ecoppia Scientific Ltd, Annual General Meeting, Dec 24, 2023 Ecoppia Scientific Ltd, Annual General Meeting, Dec 24, 2023, at 12:00 Israel Standard Time. Reported Earnings • Sep 02
First half 2023 earnings released First half 2023 results: Net loss: US$7.43m (loss narrowed 8.7% from 1H 2022). Reported Earnings • Apr 07
Full year 2022 earnings released: US$0.22 loss per share (vs US$0.14 loss in FY 2021) Full year 2022 results: US$0.22 loss per share (further deteriorated from US$0.14 loss in FY 2021). Net loss: US$21.5m (loss widened 63% from FY 2021). Reported Earnings • Dec 04
Third quarter 2022 earnings released: EPS: US$0.09 (vs US$0.04 loss in 3Q 2021) Third quarter 2022 results: EPS: US$0.09. Net loss: US$9.30m (loss widened 159% from 3Q 2021). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent External Director Adina Eckstein was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent External Director Adina Eckstein was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Aug 14
Ecoppia Scientific Ltd(TASE:ECPA) dropped from TA-125 Index Ecoppia Scientific Ltd has been removed from TA-125 Index. Is New 90 Day High Low • Mar 02
New 90-day low: ₪10.32 The company is down 30% from its price of ₪14.74 on 02 December 2020. The Israeli market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Machinery industry, which is down 1.0% over the same period. Announcement • Feb 25
Ecoppia Scientific Ltd Strengthens Its Presence in the Middle East with A First Project in Egypt Ecoppia announced a new project in one of the largest solar parks in BenBan, Egypt. BenBan solar park, located near the southern Egyptian city of Aswan, has a total capacity of 1,650 MWp corresponding to an annual production of approximately 3.8 TW, and is spread across nearly 40 km. While enjoying very high radiation rates, the facility also suffers from major soiling and desert sands, requiring frequent cleaning to ensure steady and optimal production. Ecoppia’s robotic solutions were proven to be extremely effective, cleaning nearly 10 million solar panels every night in harsh climatic conditions, spreading across roughly 2,500MW of installations globally. Not only effective, the robots were also proven to be fully safe and reliable on all module types, to include glass on glass and bifacial. Ecoppia’s unique robotic solutions are completely autonomous, water-free and energy independent, allowing site owners to enjoy the benefits of a year-round peak performance while lowering their O&M expenses and overall, their LCOE. This project in BenBan will feature the light weighted Ecoppia T4 solution, designed especially for Single Axis trackers. Announcement • Dec 15
Ecoppia Signs Another Significant Project of 450MW with Azure Power Ecoppia announced yet another significant project of 450MW signed in October with Azure Power, the renowned solar energy player. The project is now reaching advanced stages, scheduled to go live on the beginning of first quarter 2021.